Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3066 Target Snapshot

Gonadotropin-releasing hormone receptor · SINGLE PROTEIN · Rattus norvegicus

1,190Compounds
182Assays
6Approved Drugs
1,183.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P30969. Use UniProt P30969 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30969 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Gonadotropin-releasing hormone receptor as ChEMBL target CHEMBL3066, mapped to UniProt P30969. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Gonadotropin-releasing hormone receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3066
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P30969
Gonadotropin-releasing hormone receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Gonadotropin-releasing hormone receptor is the right protein anchor across sources, using UniProt P30969 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGonadotropin-releasing hormone receptor
UniProt AccessionP30969
Component TypeProtein
Sequence Length327 aa

Gonadotropin-releasing hormone receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Gonadotropin-releasing hormone receptor, mapped to UniProt P30969. Sequence length is 327 aa.

Mapped IDP30969
Review nameGonadotropin-releasing hormone receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

6
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC50778.0
KI367.0
KD38.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL409219 10.87 Ki 0.01349 Preclinical
CHEMBL268397 10.63 Ki 0.02344 Preclinical
CHEMBL263839 10.5 Ki 0.03162 Preclinical
CHEMBL263840 10.48 Ki 0.03311 Preclinical
CHEMBL268319 10.28 Ki 0.05248 Preclinical
CHEMBL268095 10.25 IC50 0.056 Preclinical
CHEMBL409990 10.21 Ki 0.06166 Preclinical
CHEMBL2370519 10.1 IC50 0.08 Preclinical
CHEMBL414113 10.1 Kd 0.08 Preclinical
CHEMBL414239 10.05 IC50 0.09 Preclinical
Distribution

pChEMBL Value Distribution

52
5.0
78
5.5
127
6.0
138
6.5
148
7.0
105
7.5
86
8.0
101
8.5
96
9.0
61
9.5
pChEMBL
Approved Drugs

Approved Drugs

RELUGOLIX
CHEMBL1800159
Approved 2019
LEUPROLIDE
CHEMBL1201199
Approved 1985
GONADORELIN
CHEMBL1007
Approved 1982
KETOCONAZOLE
CHEMBL157101
Approved 1981
Assay Landscape

Assay Landscape

182
Total Assays
851
Tested Compounds
2
Assay Types
Binding — 144 assays, 851 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 106 537 7.4
cell membrane format 14 137 7.6
cell-based format 14 126 8.1
assay format 8 41 8.4
organism-based format 2 10 5.2
Functional — 38 assays, 182 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 25 179 6.8
assay format 9 3 7.8
organism-based format 4 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine